AUTUM HOWELL: Open Payments
NPI 1871843953 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 8 payments from 6 companies in 2025. Trend: 2023 $283 · 2024 $203 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $39 |
| Madrigal Pharmaceuticals | 1 | $21 |
| PFIZER INC. | 1 | $17 |
| Celltrion USA Inc. | 1 | $16 |
Products named: DUPIXENT, EOHILIA, REZDIFFRA, VIBERZI, MAVYRET, ENTYVIO, VELSIPITY, VEGZELMA.
Industry payments across MT — which companies pay providers there.
